Overall, 29% of mice treated with WT1-28z/IL-12 exhibited long-term survival compared with 6% of mice treated with WT1-28z although this difference failed to reach statistical significance ( P = 0.06).
← all excerpts
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen.
1
0.0600
0.0600